Th2 cells, known for their anti-inflammatory properties, can delay or potentially reverse atherosclerosis progression, primarily via the secretion of cytokines like interleukin 4 (IL-4), interleukin 5 (IL-5), and interleukin 13 (IL-13) [23]. The gene discussed is IL13; the disease is atherosclerosis.